innoscripta Documenten
Documenten
0
Ticker
1INN.MU
ISIN
DE000A40QVM8
innoscripta SEC Filings
Type | Bericht | Datum |
|---|---|---|
| Geen documenten beschikbaar | ||
innoscripta Documenten 2026
Deze pagina bevat alle officiële documenten en SEC-filings voor innoscripta aandelen (1INN.MU, ISIN: DE000A40QVM8). Dit omvat jaarverslagen (Formulier 10-K), kwartaalrapporten (Formulier 10-Q) en insidertransacties (Formulier 4). Momenteel zijn 0 documenten beschikbaar. Gegevens worden regelmatig bijgewerkt om beleggers een volledig overzicht van innoscripta's regelgevingsfilings te bieden.
innoscripta Aandelenanalyse
innoscripta innoscripta SE generates revenue through its SaaS platform providing cloud-based compliance software for R&D tax credits and project management. The company serves funding consulting and support companies across various industries, offering tools for project management, time recording, employee management, and data interfaces to third-party systems. Its platform helps clients identify, validate, and manage R&D projects while ensuring compliant documentation for tax credits. The firm's SaaS solution is designed to streamline R&D process management for clients in diverse sectors. innoscripta SE's primary customers are funding consulting and support companies that assist businesses in securing R&D funding. These clients use the company's software to manage documentation, track project progress, and interface with external systems. The platform's focus on compliance and tax credit validation makes it essential for clients navigating complex regulatory environments. The company's revenue model relies on subscription-based access to its integrated software suite. The business model centers on delivering a comprehensive SaaS solution that integrates multiple functions into one platform. By combining project management, time tracking, employee management, and third-party data integration, innoscripta SE provides a unified system for R&D project oversight. This approach reduces the need for multiple software tools, appealing to clients seeking efficiency and compliance in their R&D operations.